COMMUNIQUÉS West-GlobeNewswire

Kane Biotech Completes U.S. FDA 510(k) Submission for revyve® Antimicrobial Wound Cleanser
16/09/2025
WINNIPEG, Manitoba, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech” or the “Company”) today announces that it has completed a U.S. Food and Drug Administration (“FDA”) 510(k) clearance [...]
Theratechnologies reçoit l’approbation définitive du tribunal relativement au plan d’arrangement proposé visant son acquisition par Future Pak
16/09/2025
MONTRÉAL, 16 sept. 2025 (GLOBE NEWSWIRE) -- Theratechnologies inc. (« Theratechnologies » ou la « Société ») (TSX : TH) (NASDAQ : THTX), une société biopharmaceutique au stade de la commercialisation, a annoncé aujourd’ [...]
Theratechnologies Receives Final Court Approval of Proposed Plan of Arrangement to Be Acquired by Future Pak
16/09/2025
MONTREAL, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“ Theratechnologies ” or the “ Company ”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, announced today that the Company has [...]
Nxera Pharma and Cancer Research UK Announce First Patient Dosed in Phase 2a Trial of Investigational Cancer Immunotherapy HTL0039732
17/09/2025
HTL0039732 (also known as NXE0039732) is Nxera’s novel oral EP4 antagonist being investigated to treat a wide range of solid cancers in combination with other immunotherapies Cancer Research UK’s Centre for Drug [...]
Cirtec Medical Welcomes Chris Cleary to its Board of Directors
16/09/2025
BROOKLYN PARK, Minn., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Cirtec Medical is pleased to announce that Chris Cleary has been appointed to its Board of Directors. Chris brings over thirty years of experience in corporate [...]
PharmAGRI Capital Partners Targets $10 Billion Federal Procurement Opportunity for Onshored Plant-Based Prescription Drugs Bright Green Corporation “BGXXQ” Q and A
16/09/2025
Fort Lauderdale, FL, Sept. 16, 2025 (GLOBE NEWSWIRE) -- PharmAGRI Capital Partners today announced its strategic focus on capturing a $10 billion total addressable market (TAM) in federal procurement of plant-based [...]
Sharecare, AWS, CLEAR, and Georgia Department of Community Health to discuss bringing CMS’s health tech ecosystem vision to life at Health Connect South
16/09/2025
During panel discussion, Sharecare Co-Founder and Executive Chairman Jeff Arnold to highlight company’s next-generation, AI-enabled health navigation experience, AskMD ATLANTA, Sept. 16, 2025 (GLOBE NEWSWIRE) -- [...]
Microbot Medical Announces First Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds
16/09/2025
$25.2 million in first closing and $4 million in second closing, with up to an additional approximately $63 million of potential aggregate gross proceeds upon the exercise in full of short-term preferred investment [...]
Kura Oncology Highlights Preclinical Data Demonstrating Potential of Farnesyl Transferase Inhibitors to Overcome Drug Resistance in Combination with Key Targeted Therapies Across Multiple Tumor Types
16/09/2025
Analyst/Investor event showcases opportunities for KO-2806 (darlifarnib) in combination with PI3Kα inhibitors, KRAS inhibitors and antiangiogenic tyrosine kinase inhibitors (TKIs) Preliminary clinical data and KO-2806 [...]
Cytokinetics Announces Proposed Private Placement of $550.0 Million of Convertible Senior Notes
16/09/2025
SOUTH SAN FRANCISCO, Calif., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (“Cytokinetics”) (Nasdaq: CYTK) today announced its intention to offer, subject to market conditions and other factors, $550.0 [...]
Resmed Announces Participation in the Bank of America Global Healthcare Conference 2025
16/09/2025
SAN DIEGO, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Dr. Carlos Nunez, chief medical officer, will present at the Bank of [...]
NurExone Planning to Establish First U.S. Commercial Manufacturing Facility in Indiana
16/09/2025
Secures Incentive Offer of up to US$255K to Establish Operations in Indianapolis TORONTO and HAIFA, Israel and INDIANAPOLIS, Sept. 16, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90 [...]
Teva to Host Conference Call to Discuss Data from the Completed Phase 3 SOLARIS Trial For Olanzapine LAI (TEV-‘749) on September 22, 2025 After Presentations at the Psych Congress Annual meeting
16/09/2025
TEL AVIV, Israel, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced plans to present data from the completed phase 3 SOLARIS trial at the 2025 Psych Congress [...]
HealthEx and Epic Lead Patient Access Push on TEFCA
16/09/2025
A major advancement towards a patient-centric health ecosystem SAN FRANCISCO, Sept. 16, 2025 (GLOBE NEWSWIRE) -- HealthEx today announced enhanced interoperability with Epic through the Trusted Exchange Framework and [...]
TOMI Environmental Solutions Appoints Francesco Fragasso to its Board of Directors
16/09/2025
Brings Over 25 years of Global Financial and Operational Leadership Experience Across Multiple Industries FREDERICK, Md., Sept. 16, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. ® (“TOMI”) (NASDAQ: TOMZ), [...]
MULTIMEDIA UPDATE -- Marine Biologics Partners with Molecular Quantum Solutions to Accelerate Next-Generation Biomaterials Development
16/09/2025
BERKELEY, Calif. and COPENHAGEN, Denmark, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Biomaterials company Marine Biologics today announced an exclusive strategic partnership with Molecular Quantum Solutions (MQS) in which [...]
Quetzal Therapeutics Appoints Dr. Shaad Abedin as Chief Medical Officer
16/09/2025
CHICAGO, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Quetzal Therapeutics, a biopharmaceutical company focused on developing transformative therapies for patients with rare and life-threatening diseases, today announced the [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 37 - 2025
16/09/2025
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 08 Septembre au 12 Septembre 2025 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 37 - 2025
16/09/2025
Aggregated presentation by day and by market Statement of transactions in own shares from September 08th to September 12th 2025 Name of the issue Identity code of the issuer (Legal Entity Identifier) Day of the [...]

Pages